
Pirtobrutinib’s indication was expanded for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, allowing for treatment in earlier lines of therapy.

Pirtobrutinib’s indication was expanded for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma, allowing for treatment in earlier lines of therapy.

The supplemental new drug application (sNDA) was assigned a PDUFA target action date of July 26, 2026.

Pharmacists can help close the lung cancer screening gap by identifying high-risk tobacco users, increasing awareness, and connecting eligible patients to lifesaving early detection.

A new rapid test for pertussis enables quick diagnosis in as little as 15 minutes, addressing rising whooping cough cases.



The pneumococcal 13-valent conjugate vaccine (PCV13) was effective at preventing pneumococcal lower respiratory tract infection (LRTI) in older patients from Thailand.

Unit-based pharmacists discuss the key contributions they make to the care team.

A panel of pharmacists discuss the innerworkings of unit-based pharmacy.

A cohort study of over 6 million US veterans revealed a 76% increased risk of pancreatic cancer following chronic hepatitis C infection.

A 3-month resistance exercise program helped improve walking distance, grip strength, and other parameters of physical health in patients with long COVID.

The blood test helps patients avoid unnecessary and invasive biopsies.

Depression and cardiometabolic disease share hormonal, inflammatory, and behavioral pathways requiring integrated pharmacist-led recognition and management.

Researchers reveal fibroblasts as key players in Hidradenitis Suppurativa inflammation, paving the way for innovative treatment strategies.

The FDA approves Amneal's albuterol sulfate inhalation aerosol, enhancing access to vital asthma and COPD treatments for millions of Americans.


Shivang Joshi, MD, MPH, RPh, FAHS, discusses how Symbravo’s multimechanistic fixed-dose design may address gaps in acute migraine therapy for patients who do not respond to single-agent treatments.

Research uncovers the crucial role of lipids and microglia in Alzheimer disease, revealing new therapeutic targets for treatment and brain health.

Sam Klempner, MD, discusses early findings for the bispecific T-cell engager ASP2138, including monotherapy response, combination activity, and safety enhancements through subcutaneous dosing.

Infants hospitalized with respiratory syncytial virus (RSV) bronchiolitis who were born to parents with asthma had a significantly higher risk of later developing asthma, the investigators found.

HRSA moves forward with the 340B Rebate Model Pilot Program, raising concerns among health care providers about financial impacts and operational challenges.

The National Lipid Association aims to enhance the science and practice of lipidology and promote optimal cardiometabolic health.

New research uncovers diverse tumor subgroups in triple-negative breast cancer, paving the way for personalized treatment strategies and improved patient outcomes.

In a phase 2 trial, the unimolecular agonist of GLP-1 and amylin induced major reductions in weight loss and hemoglobin A1c in patients with type 2 diabetes.




Examining Trends From Past Respiratory Virus Seasons Can Inform New Vaccination Strategies

Expanding lung cancer screening to an age-based model significantly enhances early detection, potentially saving over 26,000 lives annually in the US.

Pharmacists remain essential to ensuring patients receive safe, effective, and accessible care amid expanding therapies.